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Human and Mouse Induced Pluripotent Stem Cells
Are Differentially Reprogrammed in Response
to Kinase Inhibitors
Kunio Hirano,1,* Shogo Nagata,1,2,* Shinpei Yamaguchi,1,2 Masato Nakagawa,3 Keisuke Okita,3
Hidetoshi Kotera,2,4 Justin Ainscough,5 and Takashi Tada1,2
Conventional human induced pluripotent stem cells (hiPSCs), reprogrammed from somatic cells by induced
expression of Oct4, Sox2, Klf4, and c-Myc, are phenotypically different from mouse embryonic stem cells (ESCs).
In mice, culture in N2B27 serum-free 2i media (mitogen-activated protein kinase/extracellular signal-regulated
kinase and glycogen synthase kinase 3 inhibitors; PD0325901 and CHIR99021) plus leukemia inhibitory factor
(LIF) (2i +LIF medium) enriches for germline competent ESCs. Here, we demonstrate that flat-shaped hiPSC
colonies can be reprogrammed into bowl-shaped multi-potent stem cells (2i-hiPSCs) by using 2i +LIF medium.
Mechanical dissociation of 2i-hiPSC colonies enables stable maintenance for > 20 passages. Importantly, gene
expression profiling demonstrated that 2i-hiPSCs more closely resemble primitive neural stem cells (PNSCs).
Notably, this 2i-induced phenotype was generated from conventional hiPSCs, but not human ESCs (hESCs),
thus correlating with the observation of neuroectodermal SOX1-positive colonies in conventional hiPSCs, but not
hESCs in 2i +LIF medium. Thus, 2i-hiPSCs, which are nonteratoma forming PNSCs, may represent a safe source
of cells for neural research and regenerative medicine.
Introduction
Ground state mouse embryonic stem cells (GS-mESCs)are pluripotent cell populations with homogeneous stem
cell identity, including germline competency. They are able to
proliferate with minimal extrinsic stimuli when cultured in
serum-free neurobasal N2B27 medium in the presence of 2
small-molecule inhibitors (2i) against mitogen-activated pro-
tein kinase/extracellular signal-regulated kinase (ERK) ki-
nase (MEK) and glycogen synthase kinase 3 (GSK3), plus
leukemia inhibitory factor (LIF) (2i +LIF medium) [1]. GS-
mESCs have been derived from not only the inbred 129-strain,
but also the nonpermissive strains, including nonobese dia-
betic mice [2]. Further, germline-competent ESC lines have
been successfully generated from rat blastocysts by using
similar 2i +LIF medium [3,4]. Therefore, it is likely that plur-
ipotency, as seen in ESCs, is a state that utilizes common
molecular mechanisms which are shared between rodents. If
the pluripotent state maintained under 2i +LIF conditions is
not only a rodent-specific phenomenon, then it is theoretically
possible to generate pluripotent stem cells (PSCs) that re-
semble GS-mESCs from human ESCs (hESCs), as well as from
human induced PSCs (hiPSCs) derived from reprogrammed
somatic cells.
Oct4, Sox2, Klf4, and c-Myc (OSKM)-hiPSCs resemble
blastocyst-derived hESCs in colony morphology, global gene
expression and capacity for teratoma formation [5,6]. Intrigu-
ingly, hESC and hiPSC colonies exhibit characteristic flat-
shaped morphology, which is clearly distinct from mESC and
mouse iPSC (miPSC) colonies that have bowl-shaped mor-
phology [7]. Further, hiPSCs and hESCs can be maintained in
human ES medium with knockout serum replacement (KSR)
and basic fibroblast growth factor (bFGF) but not in mESC
medium with fetal bovine serum (FBS) and LIF. Thus, hESCs
and hiPSCs differ markedly from mESCs and miPSCs with
regard to cellular physiology. Consistentwith this, several lines
of evidence have suggested that hESCs aremore closely related
tomouse epiblast-stem cells (mEpiSCs) than they are tomESCs
[8–11]. Notably, mESC-like naı¨ve hESCs have been generated
from conventional hESCs by growth in 2i+LIF medium in the
presence of Forskolin, and from conventional hiPSCs by Dox-
inducible expression of OSKM in 2i+LIF medium, although
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establishment of stable lines from these naı¨ve cells has been
unsuccessful to date [12]. Similarly, mESC-like hESCs can be
generated from conventional hESCs in Dulbecco’s modified
Eagle’s medium (DMEM) with KSR, LIF, MEK inhibitor
PD0325901 and p38 inhibitor SB203580, although the proper-
ties of these cells have yet to be fully characterized [13]. Thus, it
remains unclear whether mESC-like hiPSCs can be reproduc-
ibly generated, and what characteristics mESC-like hiPSCs es-
tablished in 2i+LIF medium may have.
Here, we demonstrated that bowl-shaped hiPSCs (2i-
hiPSCs) can be reproducibly isolated from conventional and
integration-free (Infr) hiPSCs, but not from hESCs, in 2i+LIF
medium on feeder-free matrigel-coated dishes. Stable main-
tenance of 2i-hiPSC lines was enabled by mechanical but not
enzymatic dissociation for > 50 passages over a period of
9 months. High-level PAX6 and SOX2 expression and low-
level OCT4 and NANOG expression demonstrated that 2i-
hiPSCs had characteristics closer to multi-potent primitive
neural stem cells (PNSCs) [14] also known as neural pre-
cursors [15] than miPSCs and mESCs. On withdrawal of
2i +LIF, 2i-hiPSCs efficiently differentiated into neurons and
astrocytes in vitro. Further, 2i-hiPSCs were found to be in-
capable of forming teratomas in vivo, when implanted under
the kidney capsule of immunodeficient mice. Notably, the
differential ability of hiPSC and hESC lines to form PNSCs in




miPSC lineswere established from amniotic cells, which had
been obtained from E18.5 embryos by mating of Oct4-GFP
(C57BL/6) and Rosa26 (129/Sv) transgenic mice, by retroviral
transduction of mouse OSKM and DsRed [16]. R1 mESC
(129/Sv) and miPSC lines were maintained in mES me-
dium [DMEM/F12 supplemented with 15% FBS, L-glutamine,
penicillin-streptomycin, sodium bicarbonate, sodium pyru-
vate, 2-mercaptoethanol, and 1,000U/mL of LIF (Chemicon)].
mEpiSC lines were derived from epiblasts of E6.5 embryos
obtained from mating of DBA and C57BL/6 with the ubiqui-
tously expressing GFP transgene and cultured in mEpi me-
dium [hES medium supplemented with 8ng/mL Activin A
(Peprotech)] on mouse embryonic fibroblast (MEF) feeder cells
[8,9]. Human fetal lung fibroblasts (TIG1 and TIG3) provided
by the JCRB Cell Bankwere used to derive hiPSC lines through
retroviral induction of OSKM or OSK [16]. Infr hiPSC lines
were established byOSKM transductionwith episomal vectors
from female adult dermal fibroblasts, HDF1388 [17]. hESC
lines, KhES1, and KhES3 [18] were used according to the
guidelines for derivation and utilization of hESCs from the
ministry of education, culture, sports, science, and technology
of Japan. hESC and hiPSC lines were stably maintained in
MEF-conditioned hES medium [DMEM/F12 supplemented
with 20% KSR (Invitrogen), L-glutamine, nonessential amino
acids, 2-mercaptoethanol, and 10ng/mL bFGF (Peprotech)] on
matrigel-coated dishes. To address the effect of apoptosis on
survival, 10mM ROCK inhibitor Y27632 (Wako) and 10mM
Myosin IIA inhibitor Blebbistatin (Toronto Research Chemi-
cals) were added to 2i+LIF medium. All experiments were
performed with PSCs at 10–25 passages.
Cell culture in 2i + LIF medium
N2B27 medium was prepared as a 1:1 mixture of N2 me-
dium [DMEM/F12mediumwith N2 supplement (Invitrogen)]
and B27 medium [Neurobasal medium with B27 supplement
(Invitrogen)] supplemented with L-glutamine and penicillin-
streptomycin. 2i+LIF medium was prepared by supplement-
ing N2B27 medium with 1mM MEK inhibitor PD0325901
(Cayman chemical), 3mM GSK3 inhibitor CHIR99021 (Axon
biochemicals), and 1,000U/mL LIF (Chemicon).
For isolating GS-miPSC and GS-mESC lines, mES culture
medium was replaced with 2i +LIF medium. For establishing
GS-mEpiSC lines, 2.0 · 105 mEpiSCs were plated on 3.5 cm
culture dishes containing feeder cells, cultured in mEpi me-
dium overnight, and then cultured in 2i +LIF medium. Cells
were split and reseeded into four 3.5 cm dishes with feeder
cells after 3 days, at which time they were cultured in 2i +LIF
medium. GS-mEpiSC colonies were picked 7 days after re-
seeding and expanded in 2i +LIF medium. Established GS-
mEpiSC lines were sub-cultured with 2i +LIF medium every
3 days.
For establishing 2i-hiPSC lines, 2.0 · 105 conventional
hiPSCs were plated on matrigel-coated 3.5 cm dishes in
2i +LIF medium. Candidate colonies were picked 5 days
after 2i+LIF culture by using a micropipette. Colonies were
mechanically dissociated into 40–50 cells by repeated mi-
cropipetting. This process was repeated until 2i-hiPSC lines
were established. Established lines were subsequently sub-
cultured by mechanical dissociation in 2i +LIF medium
every 5–7 days.
Chimera and teratoma formation
For producing chimeric embryos, GS-miPSCs and GS-
mEpiSCs ubiquitously expressing b-geo and EGFP, respec-
tively, were microinjected into C57BL/6J x BDF1 blastocysts.
Embryos were collected at E15.5 and analyzed by X-gal
staining and GFP fluorescence [19].
For obtaining teratomas, undifferentiated 2i-hiPSC lines
(about 5.0 · 106 cells/site) and derived EBs (1.0 · 107 cells/
site) were transplanted under the kidney capsule of immu-
nodeficient SCID mice (Clea) by a transfer pipette. Teratoma
formation was assessed after 8–10 weeks.
Gene expression
For reverse transcription (RT)-polymerase chain reaction
(PCR) analyses, total RNA of cultured cells was extracted
with TRIzol reagent (Invitrogen). cDNA was synthesized
from 500 ng total RNA with Superscript III (Invitrogen) by
using random hexamers while following the manufacturer’s
instructions. For mEpiSC RNA extraction, mEpiSC colonies
grown on feeder cells were purified by mechanical picking
and pooled in TRIzol. Primer sequences used in this study
are summarized in Supplementary Table S1; Supplementary
Data are available online at www.liebertonline.com/scd.
For global gene expression analyses, 250 ng total RNA was
labeled according to standard Affymetrix protocols and hy-
bridized to the Affymetrix mouse genome 430 2.0 Array
(samples of mouse origin) or the human genome U133 Plus
2.0 Array (samples of human origin). Raw data were nor-
malized by the MAS 5.0 method by using bioconductor
package on R program (www.r-project.org/). Heat maps of
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gene expression profile for all genes in each cell line were
visualized by MeV program (www.tm4.org/mev/). Hier-
archical clusters were calculated by Pearson’s correlation
coefficient (r) and visualized by a pvclust package on R.
Immunocytochemistry
Cultured cells were fixed with 4% paraformaldehyde
(PFA)/phosphate-buffered saline (PBS) for 10min at room
temperature, washed with PBST (0.1% Triton X-100 in PBS),
and then pretreated with blocking solution [3% bovine se-
rum albumin and 2% skim milk (DIFCO) in PBST] at 4C
overnight. The cells were then stained with fluorescence-
conjugated secondary antibodies (1:500; Invitrogen), follow-
ing an immunoreaction with primary antibodies; anti-OCT4
(1:50; Santa Cruz Biotechnology), anti-SOX2 (1:500; Abcam),
anti-Klf4 (1:200; Santa Cruz Biotechnology), anti-NANOG
(1:200; ReproCELL), anti-SSEA1 (1:200; DSHB), anti-SSEA4
(1:200; DSHB), anti-E-CADHERIN (1:50; Takara), anti-TRA1-
60 (1:500; Millipore), anti-Tubulin J1 (TuJ1) (1:600; COV-
ANCE), anti-neurofilament-M (NF-M) (1:1,000; Millipore),
anti-glial fibrillary acidic protein (GFAP) (1:1,000; Dako),
anti-O4 (1:60; Millipore), anti-H3K27me3 (1:200; Millipore),
anti-SOX1 (1:100; R&D systems), and anti-N-CADHERIN
(1:100; Chemicon). The cells were counterstained with 4,6-
diamidino-2-phenylindole and mounted with SlowFade light
antifade kit (Invitrogen).
XIST RNA FISH
Cells were fixed with 4% PFA/PBS. RNA FISH was per-
formed according to standard procedures with an RNA
probe prepared by in vitro transcription with Cy3-UTP (GE
Healthcare) and a human full-length XIST cDNA construct
[20] using T7 RNA polymerase.
Cell differentiation in vitro
For neural differentiation, 2i-hiPSCs were cultured on
matrigel-coated dishes in N2B27 medium for 4 days after
withdrawal of 2i +LIF. Differentiated cells were fixed with
4% PFA/PBS and analyzed by immunocytochemistry.
For EB formation, small 2i-hiPSC aggregates were formed
by overnight hanging drop cultures in DMEM containing
10% FBS. Aggregates were grown and differentiated in
bacterial culture dishes for 5–7 days.
Results
Mouse GS pluripotent stem cells in 2i + LIF medium
To investigate the suitability of serum-free neurobasal
N2B27 medium with 2i +LIF (2i +LIF medium) for genera-
tion of GS PSCs, we tested 3 types of mouse conventional
PSCs: mESCs, miPSCs, and mEpiSCs. GS-mESCs, GS-
miPSCs, and GS-mEpiSCs, similarly characterized by bowl-
shaped morphology of colonies expressing Oct4, Sox2, and
Nanog proteins, were reproducibly isolated (Fig. 1A). GS-
mEpiSCs were isolated as a small number of colonies from
conventional mEpiSCs as a consequence of stringent selec-
tion in 2i +LIF medium, whereas only mild cell selection was
required for the transition from conventional mESCs and
miPSCs to GS-mESCs and GS-miPSCs, respectively. These
results were verified by triplicate experiments. Before being
cultured in 2i+LIF medium, miPSCs exhibited incomplete
silencing of exogenous Oct4, Klf4, and c-Myc, whereas mEpi-
SCs exhibited low expression of Rex1, Nr0b1, and Stella ac-
companied by high expression of Lefty1, Sox17, and Fgf5.
After culture in 2i +LIF medium, both GS-miPSCs and GS-
mEpiSCs exhibited similar gene expression patterns to GS-
mESCs (Fig. 1B). This was verified by analyses of global gene
expression profile with expression of microarray assays (Fig.
1C). The efficient contribution to a broad range of cell types
in E15.5 chimeric embryos demonstrated pluripotency; of
GS-miPSCs with the LacZ reporter gene and GS-mEpiSCs
with the GFP reporter gene (Fig. 1D). Our observations on
GS-mESCs and mEpiSCs are consistent with findings pre-
viously reported [1,8,9,21,22], thus clearly indicating that the
2i +LIF medium used here is suitable for generating and
maintaining mouse GS PSCs.
Generation of human iPSC lines in 2i + LIF medium
To determine whether human somatic cells can be directly
reprogrammed into bowl-shaped 2i-hiPSCs, the human pri-
mary fetal lung fibroblast lines, female TIG1 and male TIG3,
were cultured for 20 days after retroviral transduction of
OSKM in human ES medium with KSR and bFGF. Twenty-
four hours after replacing the culture medium with 2i +LIF,
surviving colonies were picked and expanded by gentle
dissociation with a glass pipette for 3–4 passages. This re-
sulted in numerous 2i-hiPSC colonies with bowl-shaped
mESC-like morphology (Fig. 2A).
To further investigate whether these 2i-hiPSCs had been
directly derived from the conventional flat-shaped OSKM-
hiPSCs established from the TIG1 and TIG3 cells, the culture
medium of conventional hiPSCs was switched from human
ES medium with KSR and bFGF to 2i +LIF medium. Con-
ventional hiPSC colonies were severely selected for 5 days of
culture. However, after the longer selection period (5–7
days), a small number of bowl-shaped colonies (5–10 colo-
nies from about 2.0 · 105 conventional hiPSCs) were ob-
served. The bowl-shaped colonies were picked and
expanded in fresh 2i +LIF medium after mechanical disso-
ciation by using a glass micropipette (Fig. 2A). Bowl-shaped
2i-hiPSC colonies were reproducibly established from
OSKM-hiPSC lines derived from both independent somatic
cell lines, TIG1 and TIG3. In total, more than fifty 2i-hiPSC
lines were established. Of 5 2i-hiPSC lines examined, all were
karyotypically normal 2n= 46, XY or XX (data not shown).
To examine whether 2i-hiPSCs can be generated from
iPSC lines that do not contain the integrated exogenous c-
Myc gene, conventional iPSCs produced by retroviral OSK
transduction were cultured in 2i +LIF medium. Notably, 2i-
hiPSC lines were reproducibly isolated from conventional
OSK-hiPSCs at a similar frequency to that observed from
conventional OSKM-hiPSCs. The 2i-hiPSC colonies resem-
bled those derived from OSKM-hiPSCs, with characteristic
bowl-shaped colony morphology and cell growth (Fig. 2A).
Thus, integration of c-Myc is dispensable for 2i-hiPSC gen-
eration from conventional hiPSCs.
To expand the number of 2i-hiPSCs, we also attempted
enzymatic dissociation with trypsin and collagenase. Strik-
ingly, none of the cells were capable of complete re-attachment
to matrigel-coated culture dishes. Subculture in the presence
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of the small molecule Tzv [13] was found to improve at-
tachment, but not survival. In fact, Tzv induced rapid cell
differentiation toward neuronal lineages (data not shown).
This suggested that subculture by enzymatic dissociation is
not suitable for expansion and long-term maintenance of
2i-hiPSC lines. Consequently, 2i-hiPSC colonies were rou-
tinely dissociated to clusters of 20–50 cells by using a glass
micropipette under a stereomicroscope. For stable mainte-
nance, dissociated 2i-hiPSC clusters were sub-cultured into
fresh 2i +LIF medium in matrigel-coated dishes every 5–7
days. In this manner, we were able to stably maintain and
expand 2i-hiPSC clones for > 50 passages over a period of
9 months under feeder-free conditions. Further, 2i-hiPSCs
were successfully cryo-preserved and thawed with hESC
freezing medium.
Conventional hESCs and nonintegrated hiPSCs
in 2i +LIF medium
To determine whether 2i-hESCs can be generated from
conventional hESCs without integration of exogenous genes,
conventional hESCs were cultured in 2i +LIF medium. No 2i-
hESC colonies were detected despite 3 repeated experiments
with 2 different hESC lines, KhES1 and KhES3 [18], with or
without ROCK/Myosin IIA inhibitors [23,24]; whereas 2i-
hiPSCs were repeatedly generated in the same 2i +LIF me-
dium (Fig. 2B). Further, no 2i-hESC colonies appeared even
after addition of Forskolin to the 2i +LIF medium [12]. These
findings could be explained by 2 possibilities: (1) transient
expression of exogenous OSK is required for 2i-hiPSC gen-
eration, or (2) generation potential into multipotent stem
FIG. 1. Generation of mouse ground state (GS) PSC lines. (A) Generation of mouse GS PSCs from conventional mESCs,
miPSCs, and mEpiSCs in 2i +LIF medium (GS medium). Bowl-shaped colonies of GS-mESCs, GS-miPSCs and GS-mEpiSC
colonies are positive for pluripotent marker proteins, Oct4, Sox2, and Nanog. (B) Gene expression analysis in mESC, miPSC,
and mEpiSC cultured with conventional (Conv.) and GS medium. (C) Comparative analysis of global gene expression profile
of mESC, miPSC, and mEpiSC cultured with conventional and GS medium by gene expression microarray assay. (D) E15.5
chimeric embryos generated by microinjection of GS-miPSCs and GS-mEpiSCs into host blastocysts. GS-miPSC-derivatives
are detected as blue cells by X-gal staining, whereas GS-mEpiSC-derivatives as green fluorescent cells. miPSC, mouse induced
pluripotent stem cell; LIF, leukemia inhibitory factor; mESC, mouse embryonic stem cell. mEpiSC, mouse epiblast-stem cell.
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cells in 2i +LIF medium is retained in conventional hiPSCs
but not hESCs.
To address this, 3 independent OSKM Infr conventional iPSC
lines derived from adult dermal cells HDF1388 [17] were cul-
tured in 2i+LIF medium. Importantly, 2i-iPSC lines were re-
peatedly isolated from each conventional cell line, even without
exogenous OSKM integration. Therefore, it is likely that gener-
ation of 2i-hiPSCs but not 2i-hESCs reflects differential potential
of cell reprogramming into multipotent stem cells in 2i+LIF
medium between conventional hiPSCs and hESCs.
Gene expression in 2i-hiPSCs
To explore the differential reprogramming potential of
conventional hiPSCs and hESCs in 2i+LIF medium, the
global gene expression profiles of conventional hESCs and
hiPSCs were compared with those of 2i +hiPSCs by micro-
array analyses. Notably, 2i-hiPSCs exhibited significant dif-
ferences from the conventional lines (Fig. 3A). 2i-hiPSCs
showed reduced expression of pluripotent marker genes
with the exception of SOX2. To verify the expression profile,
selected genes were further investigated by RT-PCR (Fig.
3B). Pluripotent marker genes, OCT4, NANOG, NR0B1, and
STELLA, were expressed at much reduced levels. However,
consistent with the whole genome analysis, markedly higher
levels of SOX2 expression were observed. Notably, the ex-
pression profiles and bowl-shaped colony morphology re-
sembled those of PNSCs, which are capable of contribution
into chimeras, and are defined by low level expression of the
pluripotent marker genes, Oct4 and Nanog, and high level
FIG. 2. Generation of hu-
man multipotent stem cell
lines in 2i +LIF medium. (A)
Generation of human iPSCs
(2i-hiPSCs) by reprogram-




2i +LIF medium (2i-hiPSCs).
OSK(M): Oct4, Sox2, Klf4, c-
Myc. (B) 2i-hESCs cannot be
generated from conventional
hESCs in 2i +LIF medium.
hiPSC, human induced plu-
ripotent stem cell; hESC, hu-
man embryonic stem cell.
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expression of the neuroectodermal marker genes, Nestin,
Sox1, and Pax6 in mice [14]. Thus, expression of PNSC
marker genes was analyzed. Notably, considerable high-
level SOX1 and PAX6 expression was observed in 2i-hiPSC
lines but not conventional hESC and hiPSC lines (Fig. 3C).
Expression of NESTIN was also detected in 2i-hiPSC lines, as
well as in conventional hESC and hiPSC lines. Further, an
inactivated X chromosome was detected by H3K27me3
staining and RNA FISH analysis in each female 2i-hiPSC
(Supplementary Fig. S1). Therefore, we conclude that 2i-
hiPSCs are phenotypically equivalent to mouse PNSCs, and
not authentic mESCs. 2i +LIF medium does not provide
appropriate culture conditions for generating authentic
hESCs, in contrast to generation of GS-mESCs.
Emergence of differential lineages from hESC
and hiPSC in 2i + LIF medium
Human PNSCs were generated from conventional hiPSCs
but not hESCs. Conventional hESC lines, KhES1 and KhES3,
were derived from Japanese male and female blastocysts;
whereas conventional hiPSC lines and conventional Infr
hiPSC lines were derived from fetal lung fibroblasts TIG1
and TIG3, and adult dermal fibroblasts HDF1388, respec-
tively. It is, therefore, likely that origin of the somatic cells is
not associated with differential emergence of differentiated
cells from hESC and hiPSC lines in 2i +LIF medium. To ex-
plore how the differential response occurs, we examined
expression of lineage marker genes, including PNSC mark-
ers, PAX6 and SOX1, in colonies picked for 2i-hiPSC gener-
ation 5 days after culture in 2i +LIF medium (Fig. 4A). The
reprogramming frequency to pick a colony was *30% (164
out of 536 colonies examined). Candidate colonies of 2i-
hiPSCs that appeared during culture of conventional hiPSCs
and Infr hiPSCs specifically expressed SOX1; whereas other
cell populations expressed endodermal (GATA4), mesoder-
mal (RUNX1 and T), and trophectodermal (CDX2) lineage
markers associated with down-regulation of the pluripotent
marker OCT4 (Fig. 4B). NESTIN was expressed in both
picked and other colonies, whereas PAX6 was undetectable
at the earliest conversion stage. Specific expression of the
SOX1 protein in candidate 2i-hiPSC colonies was verified by
immunostaining (Fig. 4C). These findings in human cells
were consistent with properties of PNSCs in the mouse. Sox1
is the earliest specific marker of neuroectoderm in mouse
embryos in vivo [25]. Neural precursor cells were FACS-
purified as Sox1-positive cell populations in differentiation of
mouse Sox1-GFP knock-in ES cells in vitro [15]. These data
support the notion that 2i-hiPSCs are phenotypically equiv-
alent to mouse PNSCs.
To examine which defined supplements in the culture
medium were responsible for differential emergence of
SOX1-positive colonies, conventional hiPSCs and hESCs
were cultured in N2B27 medium with or without 2i +LIF.
Differential emergence of differentiated cells between hiPSCs
and hESCs was detected only in N2B27 medium with
2i +LIF (Supplementary Fig. S2). Withdrawal of 2i+LIF in-
duced cell differentiation into both neural and non-neural
cells. Thus, we conclude that a combination of stimulatory
effect of N2B27 on cell differentiation and chemical selection
FIG. 3. Gene expression analysis of
human iPSCs in 2i+LIF medium (2i-
hiPSCs). (A) Comparative analysis of
global gene expression profile of con-
ventional (Conv.) hESC, conventional
hiPSC, and 2i-hiPSC lines by gene ex-
pression microarray assay. (B) Expres-
sion analysis of pluripotent marker
genes in conventional hESC, conven-
tional hiPSC, and 2i-hiPSC lines by
reverse transcription (RT)-PCR. (C) Ex-
pression analysis of marker genes for
primitive neural stem cells (PNSCs) in
conventional hESC, conventional hiPSC,
and 2i-hiPSC lines by RT-PCR. PCR,
polymerase chain reaction.
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of 2i +LIF-resistant neural cells is required for 2i-hiPSC
generation.
Characterization of multipotent 2i-hiPSCs
To further characterize 2i-hiPSCs, pluripotent marker
protein expression in undifferentiated human and mESCs
was examined by immunostaining. 2i-hiPSCs were positive
for OCT4, SOX2, and KLF4, weakly positive for NANOG,
and negative for E-CADHERIN, SSEA1, SSEA4, and TRA-1-
60 (Fig. 5A). Consistent with data on gene expression ana-
lyses (Fig. 3A, B), the protein expression profile of 2i-hiPSCs
was clearly different from that of conventional hESCs which
are positive for E-CADHERIN, SSEA4, and TRA-1-60. Next,
to analyze the similarity of 2i-hiPSCs to PNSCs, differentia-
tion of 2i-hiPSCs was induced in vitro. Cystic embryoid
bodies (EBs) were successfully generated within 5–7 day
suspension culture for all 2i-hiPSC lines tested (Fig. 5B), thus
indicating that 2i-hiPSCs can differentiate at least into the
endodermal lineage. Ectodermal differentiation was evi-
denced by efficient differentiation into neural cells, induced
4–5 days after withdrawal of chemicals, 2i and LIF, from
2i +LIF medium (Fig. 5B). Similar neural differentiation was
induced several days after replacement of 2i +LIF medium
with DMEM-F12 medium containing FBS (data not shown).
To determine the type of neural cells, we performed im-
munostaining on the differentiated cells. TuJ1 and NF-M-
positive neuronal cells and GFAP-positive astrocytes were
detected at a high frequency. O4-positive oligodendrocytes
were also observed, albeit at a much reduced frequency (Fig.
FIG. 4. Emergence of human
iPSCs in 2i +LIF medium (2i-
hiPSCs). (A) Generation of 2i-
hiPSCs in conventional hiPSC
and integration-free (Infr)
hiPSC but not conventional
hESC after 5 days culture in
2i +LIF medium. 2i-hiPSC col-
onies, donated by dotted lines
(picked), were used for further
RT-PCR analysis of 2i-hiPSC.
(B) Comparative RT-PCR ex-
pression analysis of lineage
marker genes in hESC, infr
hiPSC, and hiPSC at day 0 and
5 after culture in 2i +LIF me-
dium. NESTIN, PAX6, and
SOX1 are marker genes for
neuroectodermal tissues. (C)
Expression of SOX1 protein
in hiPSC colony after 5 days
culture in 2i+LIF medium.
A 2i-hiPSC colony (picked) is
demarked by dotted lines.
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5C). Thus, 2i-hiPSCs have the potential to differentiate into
all types of neurons, astrocytes, and oligodendrocytes, as
previously shown with mouse PNSCs [14]. Multi-lineage
differentiation of 2i-hiPSCs was verified by expression of
mesodermal (T) and endodermal (GATA4) lineage marker
genes in day 5 EBs (Fig. 5D). Experiments to demonstrate
contribution of 2i-hiPSCs into normal embryonic develop-
ment were not approved on ethical grounds, although effi-
cient contribution of PNSCs into aggregation chimeras in
mice suggests that 2i-hiPSCs may well have the capacity to
do so [26]. As an alternative approach, 2i-hiPSCs were im-
planted into kidney capsules of immunodeficient SCID mice
to assess their in vivo teratoma forming ability. Notably, no
teratomas was observed, from 10 independent implantations
of undifferentiated and EB-formed 2i-hiPSCs, thus indicating
that 2i-hiPSCs have considerably reduced potential for tera-
toma formation than their parental cells (Supplementary Fig.
S3A), in contrast to teratoma formation with parental con-
ventional hiPSCs (Supplementary Fig. S3B). Thus, we con-
clude that multi-potent 2i-hiPSCs that are primitively
FIG. 5. Characterization of differentiated and undifferentiated 2i-hiPSCs in vitro. (A) Expression of pluripotent marker
proteins (red) in 2i-hiPSCs detected by immunocytochemistry with specific antibodies. Cell nuclei are counterstained blue
with DAPI. (B) Differentiation of 2i-hiPSCs by embryoid body (EB) formation in suspension culture, and into neural cells by
culture in neurobasal N2B27 medium without 2i +LIF [2i +LIF (-)]. (C) Characterization of neural cell types by immunocy-
tochemistry with specific antibodies. TuJ1 (neuron-specific class III beta-tubulin) and NF-M (neurofilament-M) are markers
for neuron, GFAP (glial fibrillary acidic protein) is a marker for glia, and O4 is a marker for oligodendrocyte. Cell nuclei are
counterstained blue with DAPI. (D) RT-PCR expression analysis of lineage marker genes in day 5 (D5) EB formed with 2i-
hiPSCs. GATA4 is a marker for endodermal derivatives, whereas T is a marker for mesodermal derivatives. DAPI, 4,6-
diamidino-2-phenylindole.
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committed to neural differentiation, similar to PNSCs in
mice, may represent a suitable source of personalized re-
placement cells in practical regenerative medicine.
Discussion
We demonstrate here that a culture with 2i +LIF medium
induces reprogramming of flat-shaped human iPSCs into
bowl-shaped PNSCs, which contrasts markedly to repro-
gramming of mESCs, iPSCs, and EpiSCs into mouse bowl-
shaped GS PSCs. Human iPSCs were different from miPSCs
even with the same minimal extrinsic stimuli in 2i +LIF me-
dium (Fig. 6). In humans, 2i-hiPSCs resemble PNSCs in gene
expression profile and multipotency. They can be stably ex-
panded on matrigel-coated dishes without feeder cells by
mechanical dissociation for > 50 passages. Generation of 2i-
hiPSCs from conventional hiPSCs, but not the hESCswe used,
reflects a tendency for hiPSCs toward neuroectodermal line-
ages. Multi-potential 2i-hiPSCs, capable of differentiating into
neurons, astrocytes, and oligodendrocytes in vitro, did not
form teratomas in vivo. Together, the results indicate that 2i-
hiPSCs are a promising source of cells for human neural re-
search, pharmaceutical screening, and regenerative medicine.
Difference between human and mouse PSCs
in 2i +LIF medium
In rodents, 2i +LIF culture enriches GS PSCs characterized
by uniform stem cell identity and germline competence
[1,3,4]. This suggests that neuroectodermal differentiation
induction by neurobasal N2B27 medium and differentiation
inhibition by 2i and LIF are functionally balanced for tipping
toward stemness defined by prolonged self-renewal in the
undifferentiated state [1]. The same 2i +LIF culture condi-
tions induced a multi-potent PNSC state with conventional
hiPSCs, differing substantially from the pluripotent ES state
seen with conventional mEpiSCs (Fig. 1A) [21,22]. The dif-
ferences could be explained by at least 2 possibilities: (1)
hiPSCs and mEpiSCs contain different subpopulations of
cells that preferentially respond to the 2i +LIF culture con-
dition, and (2) although hiPSCs and mEpiSCs exhibit similar
flat-shaped colony morphology in a conventional state,
hiPSCs retain a uniquely different molecular network sig-
nature that serves to promote neural differentiation in
2i +LIF medium.
In conventional and Infr iPSC populations, isolation of
human PNSCs with 2i +LIF medium demonstrates the pos-
sibility that subpopulations of cells directly reprogrammed
into PNSCs are generated and stably maintained in human
ES medium with bFGF, which is required for primary neural
specification [15]. These PNSCs, directly reprogrammed
from somatic cell by reinforced transient expression of OSK,
are selected and expanded in 2i +LIF medium. This could
account for isolation of human PNSCs from hiPSCs but not
hESCs.
In mouse PSCs, reprogramming of ESCs into PNSCs can
be enhanced by inhibition of TGF b -related signaling me-
diated by substances including bone morphogenetic proteins
(BMPs) as a default manner of neural fate specification [26].
Consistent with this, MEK inhibitor PD0325901, inhibiting
neural differentiation through impeding ERK phosphoryla-
tion, functions to suppress neural commitment via the BMP
pathway [1]. Therefore, another explanation is differential
responses between mouse PSCs and hiPSCs to the extracel-
lular signals introduced in 2i +LIF medium. Commitment to
neural differentiation occurs in fully reprogrammed plurip-
otent hiPSCs by imperfect inhibition even in the presence of
PD0325901. If so, then commitment of PSCs to form neu-
ral cells may be negatively regulated by not only the TGF
b-related signaling pathway but also other signaling path-
ways in the humans, as demonstrated by differential fate
determination in mEpiSCs and hESCs [27] and neural
conversion of hESCs and hiPSCs using the dual-SMAD-
inhibition protocol [28]. Recently, it was reported that hESCs
were rapidly converted to homogenous PNSCs by a syner-
gistic effect of inhibitors to GSK3, TGF b, and Notch signaling
pathways [29]. hESC (H1, HUES9, and HUES1)-derived
PNSC lines efficiently (> 80%) generated by 1 week culture
with N2B27 supplemented with CHIR99021, SB431542, and
LIF were characterized by intensive analyses of expression of
rosette-type neural stem cell (NSC), central nerve system
NSC, anterior neural, and midbrain marker proteins by
immunostaining, and midbrain marker genes by RT-PCR,
and functional assays in vitro and in vivo. 2i-hiPSCs resemble
hESC-derived PNSCs [29] in the expression profile of marker
genes and proteins (Supplementary Fig. S4). Differential
FIG. 6. Schema of differential
emergence of PSCs in 2i +LIF me-
dium. In humans, PNSC emerge
from conventional (Conv.) and
Infr hiPSC, but not hESC, whereas
mouse GS PSCs are generated
from mESC, miPSC, and mEpiSC.
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requirements between human and mESCs for differentiation
into PNSCs may reflect a distinct physiology between mouse
and hESCs.
Difference between human iPSCs and ESCs
in 2i + LIF medium
Human iPSCs are functionally and molecularly indistin-
guishable from hESCs on the basis of multipotency, global
gene expression, and DNA methylation profile [5,6,30]. Re-
cent intensive research, however, demonstrated differential
gene expression and DNA methylation between ESCs and
iPSCs. Early passage iPSCs retained epigenetic memory in-
herited from their somatic cell origin, and dominantly dif-
ferentiated into the cell type of origin. However, somatic
epigenetic memory disappeared on continuous sub-culturing
for both the human [31] and mouse cells [32]. Further ana-
lyses of whole-genome profiles of DNA methylation re-
vealed that substantial hyper- and hypo-methylated CpG
islands (differentially methylated regions) generated by ab-
errant and incomplete reprogramming existed in hiPSCs
compared with hESCs [33,34]. Therefore, differential differ-
entiation potentials between hiPSCs and hESCs in 2i+LIF
medium may reflect differential epigenetic memory gener-
ated through inadequate reprogramming of somatic cells
into hiPSCs. Here, we have ruled out the possibility of re-
sidual somatic epigenetic memory by using late-passage
hiPSCs derived from 2 different somatic cell types. It is,
however, possible that the hiPSCs cell lines we used are
primed for differentiation into neuroectodermal lineages by
DNA hypo-methylation of the promoter regions of key genes
for neural differentiation. This, however, is not consistent
with previous reports of low differentiation efficiency of
hiPSCs into neural cells [35]. If so, then 2i-hESC lines may be
established from some hESC lines, which have robust po-
tentials of differentiating into neural cells [34] in 2i +LIF
medium.
Stable maintenance of multipotent 2i-hiPSC lines
An intriguing property of 2i-hiPSCs is lack of expression
of SSEA4 and E-CADHERIN, which is different from con-
ventional hESCs and hiPSCs (Fig. 5A). In conventional
hESCs, Ca2 + -dependent E-CADHERIN-mediated cell-to-cell
adhesion prevents apoptosis by ROCK/myosin hyper-
activation [36]. No improvement in survival and prolifera-
tion of 2i-hiPSCs was detected with the treatment of ROCK
inhibitor Y27632, or Myosin IIA inhibitor Blebbistatin [23,24]
through subculture by enzymatic dissociation (data not shown).
This is consistent with our observation that 2i-hiPSCs can
be stably maintained by mechanical dissociation into 40–50
cell clusters but not enzymatic dissociation into single
cells. However, it is consistent with no expression of E-
CADHERIN in 2i-hiPSCs. Thus, it is speculated that other
cell-to-cell adhesion molecules involved in inhibition of
apoptosis, such as N-CADHERIN [29,37], may play an im-
portant role in survival of 2i-hiPSCs and human PNSCs in
2i +LIF medium. The putative role of cell adhesion molecule
function, in maintaining a multipotent state of 2i-hiPSCs, is
supported by induction of neural differentiation in chemi-
cally defined serum-free, feeder-layer free, and low-density
culture conditions [26] and in enzymatic dissociation into
single cells in 2i +LIF medium (data not shown).
Establishment of authentic human iPSCs
from conventional hiPSCs
A few studies demonstrated that naı¨ve hESCs or hiPSCs,
which are an authentic counterpart of mESCs, could be
generated but not maintained during long-term in vitro
culture [12,13]. Naı¨ve hESCs can be defined by bowl-shaped
colony morphology, 2 active X chromosomes in female
cells, pluripotency, and gene expression and epigenetic
profile closely similar to those of mESCs. With regard to
X-chromosome state, 2 active X chromosomes in an XX
female cell are a hallmark of naı¨ve ESCs in the mouse. In
humans, one of 2X chromosomes is inactivated in conven-
tional hESCs [20,38]. Interestingly, reducing the oxygen
concentration from conventional 20% to physiological 5%
in culture induces derivation of hESCs retaining 2 active X
chromosomes [39]. In miPSCs, it is evident that an adequate
culture condition enables establishment of naı¨ve iPSC lines
from various types of somatic cells by forced expression of
transcription factors, OSKM or OSK, thus suggesting that
transient expression of the transcription factors is sufficient
for generating naı¨ve hiPSCs with 2 active X chromosomes in
females. This suggests that naı¨ve hiPSCs could be established
if appropriate specialized culture conditions were found and
applied, that differ from current hESC culture conditions
with KSR and bFGF. Establishment of naı¨ve hiPSCs would
provide a significant contribution to the study of mecha-
nisms involved in early human embryonic development and
regenerative medicine.
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